NewGenIvf CEO exercises options for 139,811 shares

Reported share amounts reflect two 1-for-3 reverse stock splits implemented on July 6 and September 1, 2026.

Rhea-AI Filing Summary

NewGenIvf Group Ltd (NIVF) Chairman & CEO Wing Fung Alfred Siu exercised vested stock options on October 5, 2026, acquiring 139,811 Class B Ordinary Shares at $0.0001 per share. The options were granted under the issuer’s 2024 Share Incentive Plan and agreements dated July 8 and August 17, 2026. His reported direct holdings after the transaction were 146,132 Class B Ordinary Shares. Reported share amounts reflect two 1-for-3 reverse stock splits implemented on July 6 and September 1, 2026; the post-transaction amount includes 6,321 historically held shares, adjusted from 56,881 pre-split shares.

Insider Trade Summary

139,811 shares exercised/converted

Exercise 3 txns

Insider Siu Wing Fung Alfred

Role Chairman & CEO

Type	Security	Shares	Price	Value
Exercise	Stock Options (Right to Buy)	49,098	$0.00	$0.00
Exercise	Stock Options (Right to Buy)	90,713	$0.00	$0.00
Exercise	Class B Ordinary Shares F1, F2	139,811	$0.0001	$13.98

Holdings After Transaction: Stock Options (Right to Buy) — 0 contracts (Direct); Class B Ordinary Shares — 146,132 shares (Direct)

Footnotes (2)

1. F1. The Class B Ordinary Shares were acquired through the exercise of vested stock options ("Options"). The Options were granted pursuant to the Issuer's 2024 Share Incentive Plan and the employee share option agreement, dated July 8, 2026 and August 17, 2026, between the Issuer and the Reporting Person (the "Option Agreement"). The options were exercised by the Reporting Person on October 5, 2026.
2. F2. The share amounts reported herein have been adjusted to reflect two 1-for-3 reverse-stock-splits implemented by the Issuer on July 6, 2026 and September 1, 2026. The amount of securities beneficially owned following the reported transaction reflects: (i) 139,811 Class B Ordinary Shares issued under this exercise, and (ii) 6,321 Class B Ordinary Shares historically held (adjusted from the 56,881 pre-reverse-split shares previously reported).

Key Figures

Shares acquired through option exercise: 139,811 Class B Ordinary Shares Exercise price: $0.0001 per share Direct holdings after transaction: 146,132 Class B Ordinary Shares +3 more

6 metrics

Shares acquired through option exercise 139,811 Class B Ordinary Shares October 5, 2026

Exercise price $0.0001 per share For the reported option exercise

Direct holdings after transaction 146,132 Class B Ordinary Shares Following the October 5, 2026 transaction

Historically held shares included after transaction 6,321 Class B Ordinary Shares Adjusted for the reverse stock splits

Previously reported pre-split holdings 56,881 Class B Ordinary Shares Historical shares adjusted in the reported post-transaction amount

Reverse stock split ratio Two 1-for-3 reverse stock splits Implemented July 6 and September 1, 2026

Key Terms

vested stock options, 2024 Share Incentive Plan, reverse-stock-splits, beneficially owned

4 terms

vested stock options financial

"acquired through the exercise of vested stock options"

Vested stock options are the portions of an employee’s stock option grant that they have earned the right to buy at a predetermined price after meeting time or performance conditions. For investors, vested options matter because they can convert into actual shares that dilute existing ownership or signal insiders’ confidence when exercised or sold, much like a voucher that becomes redeemable and can change how many tickets are in circulation.

2024 Share Incentive Plan financial

"granted pursuant to the Issuer's 2024 Share Incentive Plan"

reverse-stock-splits technical

"two 1-for-3 reverse-stock-splits implemented by the Issuer"

beneficially owned financial

"amount of securities beneficially owned following the reported transaction"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many NIVF shares did Chairman & CEO Wing Fung Alfred Siu acquire, and at what price?

Wing Fung Alfred Siu, NewGenIvf Group Ltd’s Chairman & CEO, exercised vested stock options on October 5, 2026, acquiring 139,811 Class B Ordinary Shares at $0.0001 per share. His reported direct holdings following the exercise were 146,132 Class B Ordinary Shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/06/2026 - 10:58 AM Accepted by SEC EDGAR 10/06/2026 - 10:58 AM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Siu Wing Fung Alfred

(Last) (First) (Middle)

C/O 1/F, PIER 2, CENTRAL

(Street)

HONG KONG

(City) (State) (Zip)

HONG KONG

(Country)

2. Issuer Name and Ticker or Trading Symbol
NewGenIvf Group Ltd [ NIVF ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chairman & CEO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
10/05/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class B Ordinary Shares	10/05/2026		M		139,811	A(1)	$0.0001	146,132(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Options (Right to Buy)	$0.0001	10/05/2026	10/05/2026	M			49,098	07/08/2026	07/08/2033	Class B Ordinary Shares	49,098	$0	0	D
Stock Options (Right to Buy)	$0.0001	10/05/2026	10/05/2026	M			90,713	08/17/2026	08/17/2033	Class B Ordinary Shares	90,713	$0	0	D

Explanation of Responses:

1. The Class B Ordinary Shares were acquired through the exercise of vested stock options ("Options"). The Options were granted pursuant to the Issuer's 2024 Share Incentive Plan and the employee share option agreement, dated July 8, 2026 and August 17, 2026, between the Issuer and the Reporting Person (the "Option Agreement"). The options were exercised by the Reporting Person on October 5, 2026.

2. The share amounts reported herein have been adjusted to reflect two 1-for-3 reverse-stock-splits implemented by the Issuer on July 6, 2026 and September 1, 2026. The amount of securities beneficially owned following the reported transaction reflects: (i) 139,811 Class B Ordinary Shares issued under this exercise, and (ii) 6,321 Class B Ordinary Shares historically held (adjusted from the 56,881 pre-reverse-split shares previously reported).

	/s/ Wing Fung Alfred Siu	10/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)